Centro de Investigación Biomédica en Red sobre Enfermedades Raras -ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2015

  1. G1/S Cell Cycle Checkpoint Dysfunction in Lymphoblasts from Sporadic Parkinson’s Disease Patients

    Molecular Neurobiology, Vol. 52, Núm. 1, pp. 386-398

2013

  1. Calmodulin levels in blood cells as a potential biomarker of Alzheimer's disease

    Alzheimer's Research and Therapy, Vol. 5, Núm. 6

  2. Downregulation of extracellular signal-regulated kinase 1/2 activity by calmodulin KII modulates p21Cip1 levels and survival of immortalized lymphocytes from Alzheimer's disease patients

    Neurobiology of Aging, Vol. 34, Núm. 4, pp. 1090-1100

2012

  1. Altered calmodulin degradation and signaling in non-neuronal cells from Alzheimer's disease patients

    Current Alzheimer Research, Vol. 9, Núm. 3, pp. 267-277

2010

  1. Simvastatin overcomes the resistance to serum withdrawal-induced apoptosis of lymphocytes from Alzheimer's disease patients

    Cellular and Molecular Life Sciences, Vol. 67, Núm. 24, pp. 4257-4268

2009

  1. Distinct regulation of cell cycle and survival in lymphocytes from patients with Alzheimer's disease and amyotrophic lateral sclerosis

    International Journal of Clinical and Experimental Pathology, Vol. 2, Núm. 4, pp. 390-398

2008

  1. On the mechanism of inhibition of p27 degradation by 15-deoxy- Δ12,14-prostaglandin J 2 in lymphoblasts of Alzheimer's disease patients

    Cellular and Molecular Life Sciences, Vol. 65, Núm. 21, pp. 3507-3519